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Laboratory Diagnosis of Dysplastic Nevus Syndrome? 
Moriwaki et al (p. 7) describe a laboratory test, using Iymphoblastoid 
cells derived from peripheral blood, that detects a 2 - 3-fold increase 
in ultraviolet (UV) - induced mutations in patients with dysplastic 
nevus syndrome (DNS). Although the diagnosis is fairly straight-
forward in florid familial cases, not all DNS patients have such 
obvious clinical signs, and the histopathologic findings may be 
equivocal and controversial when the clinical signs are less pro-
nounced. Moriwaki et al present evidence that three DNS patients 
fail to repair UV-damaged DNA as well as controls. They treated a 
plasmid with UV radiation to produce DNA damage and then in-
troduced the plasmid into patients' immortalized peripheral blood 
cells. As the plasmid passes through the patient's cells, the UV-in-
duced damage is repaired by the patient's cellular repair enzymes. 
Because repair of UV damage in the plasmid depends on the repair 
enzymes of the host cell from the patient, repair of the damaged 
plasmid/DNA can be used as an assay for DNA repair. In three 
patients with DNS, the UV-induced damage in the plasmid DNA 
was repaired less effectively than in cells from controls resulting in 
an increased frequency of mutations. The plasmid used in these 
studies is called a "shuttle vector" because it receives damage outside 
the cell, enters the cell to be repaired, and then is assayed for repair of 
DNA damage after removal from the cell. Shuttle vector assays have 
been used to detect the repair defect in xeroderma pigmentosum (see 
for example] Invest DermatoI101:744-748, 1993). Although the 
increase in mutations detected by the test will need to be validated 
by studies in additional patients, it raises the possibility of a labora-
tory diagnosis of DNS. 
Nerve Growth Factor: A Mitogen for Epidermal Keratinocytes 
In this issue, Pincelli et al (p. 13) show that nerve growth factor 
(NGF) stimulates proliferative growth of human keratinocytes. 
This growth factor was discovered about 40 years ago by the Italian 
Nobel Prize winner Rita Levi-Montalcini as a peptide that played a 
crucial role in the maintenance and development of sensory and 
sympathetic neurons. It has been detected recently in the skin, and 
cutaneous nerve fibers have been found to have a low-affinity recep-
tor for NGF (Fantini et al, ] Invest DermatoI99:732-734, 1992). 
NGF not only supports growth and differentiation of nerves but 
also has effects on non-neuronal cells. In studies of NGF on skin 
cells, Pincelli et al confirmed an earlier finding that keratinocytes 
synthesize NGF and also found that secretion is highest in prolifer-
ating cells. By studies of both protein and mRNA, these investiga-
tors found evidence for both high- and low-affinity receptors, but 
only blockade of high-affinity receptors prevented stimulation of 
growth of keratinocytes, suggesting that these are the important 
receptors for keratinocyte growth. These studies raise the possibility 
that NGF may be involved in disorders of keratinocyte prolifera-
tion, such as psoriasis. 
If Acrodermatitis Chronica Atrophicans Is Caused by Borrelia burgdoiferi, Why Is It So Uncommon 
in the United States? 
Although erythema chronicum migrans (ECM) and acrodermatitis 
chronica atrophicans (ACA) were originally thought to be unre-
lated, evidence over the last few decades has implicated Borrelia 
burgdoiferi in the pathogenesis of both skin lesions. Wienecke et al 
have now found that although three different subtypes of the orga-
nism can cause ECM, only one is present in their biopsies of ACA. 
Previous studies have used Western blots to detect antibodies to 
Borrelia organisms in serum, but analysis of antibodies is an indirect 
method for detection and subtyping of the organism, because it 
relies on a patient'S immune response. Wienecke et al developed a 
more sensitive method based on amplification of gene sequences 
specific for Borrelia subtypes by the polymerase chain reaction, fol-
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lowed by transcription of the products into complementary RNA 
(as reported in Lancet 341:830-831,1993; see also Volkenandt et ai, 
1 Invest DermatoI101:514-516, 1993) and used the method to ana-
lyze formalin-fixed biopsies. Biopsies from lesions of ACA con-
tained genes from only one subtype of Borrelia organisms, but le-
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sions of ECM contained genes from all three known subtypes of 
Borrelia burgdorJeri. These findings may explain why ACA is uncom-
mon in the United States, because the single subtype found to be 
associated with ACA is rarely encountered there. 
Inflammation in the Dermis from UVB Radiation? 
Cornelius et al (p. 23) show in this issue that endothelial cells de-
rived from the skin respond to UVB by increasing their surface 
expression of the adhesion molecule intercellular adhesion mole-
cule (ICAM-1). When endothelial cells upregulate ICAM-1, circu-
lating leukocytes can bind to the "activated" endothelium by means 
oflymphocyte function-associated antigen-1 (LFA-1), an integrin 
receptor complex on the leukocyte surface, and subsequently mi-
grate through blood vessels to produce an inflammatory response. 
The result found was specific for ICAM-1, because other endothe-
lial cell surface adhesion molecules tested, such as vascular cell ad-
hesion molecule-l (VCAM-1) and E-selectin, were not affected. To 
find out whether the effect might be mediated by cytokines such as 
interleukin-1 and tumor necrosis factor-a released as a consequence 
of irradiation, the authors used antibodies to try to blunt the increase 
in I CAM-1 but were unsuccessful, which suggests that the action of 
UVB may be a direct effect. (There are no other types of cells to 
mediate the effects in these experiments, which were performed on 
isolated microvascular endothelial cells.) These results indicate that 
UVB radiation may incite inflammation, in part at least, through an 
effect on endothelial cells in the cutaneous microvasculature. Al-
though only about 10% ofUVB penetrates as far as the dermis, even 
a small amount of this highly energetic radiation may be effective in 
stimulating an inflammatory response. These studies were per-
formed with endothelial cells in vitro, so further work will be neces-
sary to find out whether this occurs in skin. 
When Do T-Cell Clones Arise in Cutaneous Lymphoma-Early or Late? 
Wood et al (p. 34) have found that clones ofT cells can be found in 
the skin of cutaneous T-cell lymphoma (CTCL) patients even in its 
earliest recognizable patch phase. Although clones ofT cells bear-
ing T-cell receptor gene rearrangements were found in advanced 
CTCL a decade ago, it has not been possible to determine whether 
these clones developed early in the disease and were a primary, 
critical part of its pathogenesis or whether they developed later as a 
consequence and were secondary. Southern blotting, ordinarily 
used to detect T-cell receptor gene rearrangements, can only detect 
clones that make up at least 1 % of T celJs and may fail to detect 
clones in early patch phase disease (see Ralfkiaer et al,] Invest Derma-
tol 88:762- 765, 1987, and Dosaka et aI,] Invest Dermatol 93:626, 
1989). Wood et al used a tenfold more sensitive technique involving 
the polymerase chain reaction and electrophoresis of amplified seg-
ments of the T-cell receptor y gene (PCR/DGGE). The more sensi-
tive methodology can detect a clone consisting of only 0.1 % of T 
cells, permitting a "closer look." Interestingly the authors also de-
tected T-cell clones in some cases of apparent chronic dermatitis 
characterized by histopathologically non-specific infiltrates. Long-
term follow-up will be needed to determine whether cases with 
now-detectable T-cell clones called "clonal dermatitis" by the in-
vestigators, are an early manifestation of CTCL. 
Th-l and Th-2 Profiles in Cutaneous T-Cell Lymphoma 
The paradigm for Th-1 and Th-2 responses may be leprosy, in 
which the Th-1 profile is found at the tuberculoid end of the spec-
trum and the Th-2 profile in lepromatous disease (see a recent re-
view of this subject in the June issue U Invest Dermatoll03:828-
832, 1994]), and evidence is accumulating that numerous other 
conditions may sort into one or the other of these categories. Lym-
phocytes in these conditions produce a characteristic profile of cyto-
kines that affect the immune system in a predictable way. The Th-l 
response is characterized by lymphocytes that produce IL-2, IFN-y, 
and lymphotoxin and by enhanced cell-mediated immunity and 
activation of macrophages. Th-2 lymphocytes produce IL-4, IL-5, 
and IL-IO, which augment humoral responses while suppressing 
cellular immunity. In this issue, Saed et al (p. 29) describe finding 
evidence for Th-1lymphocytes in CTCL patients with the clinical 
findings of mycosis fungoides, and similar evidence for a Th-2 
response in Sezary syndrome. The authors found evidence for cyto-
kine mRNA in tissues by means of the highly sensitive combined 
reverse transcriptase and polymerase chain reactions (RT-PCR). 
They speculate that progression of CTCL is associated with loss of 
benign reactive Th-l cells, which augment cellular immunity, and 
an increase in Th-2 cells. This hypothesis will be evaluated in future 
studies. 
